biofertilizer
Commented by Fabian Lorenz on October 9th, 2026 | 07:30 CEST
Deutz Stock Under Pressure! Buy Recommendations for Bayer and Partner MustGrow Biologics
Created and Published on Behalf of MustGrow Biologics Corp.
What is going on with Deutz? The Cologne-based company had emerged as a favourite among investors looking to capitalize on the defence boom. But after more than doubling in just a few months, the stock has recently fallen by around 20%. There are clear reasons for the pullback—but should investors be worried? There is certainly reason for optimism at MustGrow. The US commercialization of the soil-fertility product TerraSante™ has begun, and demand is outpacing supply. Contract manufacturers now need to ramp up production quickly. Analysts expect revenues and earnings to rise sharply in the coming years. A partnership with Bayer is also expected to contribute to this growth. Bayer, meanwhile, plans to expand its US presence with a multibillion-dollar investment. The stock is not currently benefiting from this development. Nevertheless, analysts are recommending the shares as a Buy.
Read
Commented by André Will-Laudien on October 7th, 2026 | 09:00 CEST
Droughts, Floods, Wars! Crisis-Resilient Returns with Global Food Stocks Like Unilever, MustGrow, Bayer and Kraft Heinz
Created and Published on Behalf of MustGrow Biologics Corp.
In times of heightened geopolitical and climate-related crises, the food and agriculture sector is emerging as an increasingly critical industry. Droughts, storms, and devastating floods are presenting the global food industry with ever-greater challenges. Companies in this sector are committed to ensuring basic food security and are also driving the adoption of more sustainable farming practices. For investors, Bayer, Unilever, MustGrow, and Kraft Heinz are being put to the test, with their fundamental strength facing increasingly difficult conditions. British consumer-goods giant Unilever, for example, is placing greater emphasis on regenerative agriculture while leveraging its portfolio of global brands. US food giant Kraft Heinz, meanwhile, is seeking to withstand inflation and volatile supply chains with its portfolio of established consumer brands. At the same time, biotech company MustGrow is positioning itself with sustainable agricultural solutions designed to address increasingly extreme weather conditions, while collaborating with crop-science specialist Bayer. Current challenges are pushing food producers' business models to their limits. A closer look at the key metrics reveals who is truly prepared for the future of food.
Read
Commented by Armin Schulz on October 3rd, 2026 | 06:00 CEST
Bayer, MustGrow Biologics, BASF: From Yesterday's Crop Protection to Tomorrow's Biologicals
Created and Published on Behalf of MustGrow Biologics Corp.
Major agricultural companies are reshaping their businesses and increasingly looking to small specialists. On September 2, Bayer presented its goals for the agricultural business through 2029 to investors. The Leverkusen-based company aims to generate more than EUR 3 billion in free operating cash flow by then and to assume a leading global role in biologicals through partnerships. That could work in the favor of small developers like MustGrow Biologics. On September 14, BASF commissioned four banks to prepare for a potential initial public offering (IPO) of its agricultural division, which generated EUR 9.6 billion in revenue in 2025. We therefore take a closer look at Bayer, MustGrow Biologics and BASF.
Read
Commented by Stefan Feulner on September 30th, 2026 | 07:00 CEST
FMC, MustGrow Biologics, Corteva: The Technology Transforming Agriculture
Created and Published on Behalf of MustGrow Biologics Corp.
Agriculture is under enormous pressure to innovate. Pests are developing resistance, extreme weather events are threatening crops, and pressure is mounting to reduce the use of traditional chemicals and fertilizers. As a result, a technological race is underway among agricultural corporations. Biological crop-protection products, artificial intelligence and gene editing are being used to make plants more resilient and protect yields. An industry dominated by synthetic chemistry for decades could undergo fundamental changes in the years ahead.
Read
Commented by André Will-Laudien on September 21st, 2026 | 07:00 CEST
Gas Prices Above EUR 2.50? Nel ASA, Bayer, MustGrow and K+S in the Spotlight
Created and Published on Behalf of MustGrow Biologics Corp.
The ongoing debate over rising energy costs and the transition toward a greener economy is increasingly reaching gas stations and supermarket shelves. If gasoline prices remain sustainably above EUR 2.50, agricultural producers in particular will come under enormous pressure. Food production remains heavily dependent on fossil fuels, as tractors and harvesters are traditionally powered by agricultural diesel. Higher fuel prices therefore directly increase the cost of producing and transporting our daily food. At the same time, the agricultural sector faces the enormous challenge of reducing its reliance on conventional chemicals and fertilizers and finding more sustainable alternatives. This transformation requires innovative approaches at the intersection of the energy and agricultural sectors. Companies such as Nel ASA are therefore moving into focus, as green hydrogen can play a key role in decarbonizing the agricultural sector and producing cleaner fuels. Specialists such as MustGrow Biologics are also gaining importance by developing biological crop protection products designed to replace chemical alternatives. The traditional fertilizer giant K+S is likewise a key player in the rapidly evolving sector of sustainable food. Where are the opportunities for investors?
Read
Commented by Jens Castner on September 17th, 2026 | 08:50 CEST
From Farm to Supermarket Shelf: MustGrow Biologics, Sprouts and Hain Celestial Fuel the Appetite for Organic
Created and Published on Behalf of MustGrow Biologics Corp.
Healthy, sustainable, organic: the trend toward conscious eating shows no signs of slowing down. Yet the sector has recently disappointed on the stock market. Soaring costs for raw materials and logistics are eating into producers' margins, while inflation is forcing consumers to be more cautious at the checkout. But these lean years can also create opportunities. A closer look at the entire value chain, from the field to the supermarket shelf, reveals three very different cases: MustGrow Biologics, Hain Celestial and Sprouts Farmers Market. A comparison of the trio reveals where analysts see the greatest upside potential.
Read
Commented by Armin Schulz on September 10th, 2026 | 06:50 CEST
Brussels Is Driving the Billion-Dollar Fertilizer Market: Can Bayer, MustGrow Biologics and K+S Benefit?
Created and Published on Behalf of MustGrow Biologics Corp.
Agriculture is in crisis, creating a billion-dollar market that few investors can afford to ignore. Brussels is imposing ever tighter restrictions on chemical crop protection products in Europe, while soils around the world are becoming increasingly depleted. Those still relying on conventional fertilizers today risk falling behind in the long run. Demand is rising for organic crop protection products and fertilizers that deliver high yields while still meeting environmental requirements. Three stocks show how differently investors can profit from the biological revolution in soil health: Bayer, MustGrow Biologics, and K+S.
Read
Commented by Fabian Lorenz on September 9th, 2026 | 07:00 CEST
Evotec Under Pressure! Analysts See Upside Potential - News From MustGrow and Bayer
Created and Published on Behalf of MustGrow Biologics Corp.
Alarm bells are ringing at Evotec. The share price is at risk of slipping below the EUR 3 mark. Even at this seemingly low price level, analysts are notably reluctant to issue "Buy" recommendations. Evotec has, however, announced a research collaboration to develop new T-cell-activating therapeutic approaches for solid tumors. MustGrow's story is now gaining noticeable momentum. The Canadian AgTech company reached profitability in the first half of the year and expects revenue to increase in the second half. In addition, the first milestone payment from Bayer under their licensing agreement has been received. Further payments running into the millions could follow in the coming years and exceed MustGrow's current market capitalization. Analysts see potential for significant upside. Bayer itself has announced an intensive phase of new product launches for its Crop Science division. Analysts recommend buying the stock.
Read
Commented by Nico Popp on August 25th, 2026 | 07:00 CEST
Goodbye to Chemical Pesticides: Bayer Partner MustGrow Biologics Makes Progress – Has Bioceres Overreached?
Created and Published on Behalf of MustGrow Biologics Corp.
Agriculture is at a turning point. Strict environmental regulations are increasingly pushing chemical crop-protection products off the fields. At the same time, the effects of climate change are creating additional challenges. This puts farmers in a difficult position: on the one hand, they need to secure yields, while on the other, they must comply with increasingly stringent regulations. The solution could lie in biological alternatives to conventional chemical pesticides. This market is growing rapidly and opening up opportunities for innovative companies. We take a look at the latest trends and highlight some exciting companies.
Read
Commented by Armin Schulz on July 20th, 2026 | 07:20 CEST
Profit from the Patents and Technological Moats of SAP, MustGrow Biologics, and TSMC
Created and published on behalf of MustGrow Biologics Corp.
In an era where business models can be copied almost as quickly as your morning coffee order, a true competitive advantage no longer comes from good ideas alone. Instead, it is built on the rare kind of technology that cannot easily be replicated—platforms backed by decades of proprietary data, manufacturing processes requiring multi-billion-dollar investments, or patented technologies protected by significant regulatory barriers. Companies that possess these durable competitive moats secure not only margins but entire markets. Three companies embody this approach in completely different ways—and could provide investors with a blueprint for above-average returns. We take a closer look at SAP, MustGrow Biologics, and TSMC.
Read